Ledger.Open graph →
SEC Form D · filed December 27, 2019

ZETAGEN THERAPEUTICS, INC

Offering
$8.5M
Sold
$840K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SYRACUSE, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Peter B. Finn · Boston, MAExecJoshua Resnick · Boston, MAExec · DirectorNikhil Thakur, Md · Andover, MAExec · DirectorJoe C. Loy · Weatherford, TXExec · DirectorHans Miller · Arlington, VAExecGregory M. Gentile · New York, NYExec · DirectorRobert Poulin · Arlington, VAExec · DirectorAndrew Levin · Boston, MAExecNicholas Bienstock · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗